Similarly, everolimus, a specific mTOR inhibitor, reduced IL-6 levels and alleviated the cachectic phenotype of CT-26 colon cancer bearing mice in which IL-6 is the main cachectic driver [144,145]. The gene discussed is IL6; the disease is colonic neoplasm.